Targeting CMV Reactivation to Optimize Care for Critically Ill COVID-19 Patients: A Review on the Therapeutic Potential of Antiviral Treatment

Cytomegalovirus (CMV) reactivation has been linked to adverse clinical outcomes in critically ill patients, with emerging evidence suggesting a potential connection with severe COVID-19. Mechanisms driving this association may include primary lung injury, amplification of systemic inflammation, and...

Descripción completa

Detalles Bibliográficos
Autores principales: Schinas, Georgios, Moustaka, Vasiliki, Polyzou, Eleni, Almyroudi, Maria Panagiota, Dimopoulos, George, Akinosoglou, Karolina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10221621/
https://www.ncbi.nlm.nih.gov/pubmed/37243251
http://dx.doi.org/10.3390/v15051165

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10221621/
https://www.ncbi.nlm.nih.gov/pubmed/37243251
http://dx.doi.org/10.3390/v15051165

Ejemplares similares